This document presents the results of a survey study examining the symptoms of AIDS from an Ayurvedic perspective, with reference to Charaka Samhita. 100 HIV-positive patients were surveyed about 11 symptoms of Rajayakshma and 8 symptoms of Ojakshaya described in Charaka Samhita. The results found that 69% of patients exhibited 8-11 Rajayakshma symptoms, while 92% exhibited 7-8 Ojakshaya symptoms. This suggests that AIDS correlates more strongly with the description of Ojakshaya in Charaka Samhita. The study concludes that AIDS can be understood in Ayurveda as a manifestation of both Rajayakshma and Oj
astasthana pareeksha-
1.Nadi -The pulse
2.Mootram – The urine
3.Malam --The faeces
4.Jihwa – The tongue
5.Sabda – The voice
6.Sparsa – Examination by palpation
7.Drik -- The eyes
8.Akriti – Dimentions of the body
Lifestyle Disease or NCD (non communicable diseases / diseases of civilization) are diseases that appear to increase in frequency as countries become industrialized and life span increases.
The concept of pathya apathya w.s.r. to charak samhitabrijeshbhu
Ayurveda has holistic and scientific approach in health management. It emphasizes much more on diet and regimen along with medicines. The diet and regimen which is beneficial to the body and gives the happiness to the mind is known as Pathya and opposite to that is known as Apathya. Most of the health problems develop due to the faulty eating habits and regimen. Ayurveda deals with the pathya vyavastha (planning of diet- dietetics) in a very scientific way. The planning of diet mentioned in our classical literature is very rational and based on certain principles. Lot of importance is given to the diet with regard to its processing, quality, quantity and so on.
Due consideration is given to the atmosphere, psychological condition, status of health, digestion etc. of the person while dealing with this issue. The diet should also be planned according to the age, season, habitat and the preference of the person.
Update on Ayurveda & Unani - 2009 on 14-15th November 2009 in Bal Gandharv Rangmandir, Pune organised by Maharastra University of Health Sciences, Regional Centre, AUNDH, Pune
astasthana pareeksha-
1.Nadi -The pulse
2.Mootram – The urine
3.Malam --The faeces
4.Jihwa – The tongue
5.Sabda – The voice
6.Sparsa – Examination by palpation
7.Drik -- The eyes
8.Akriti – Dimentions of the body
Lifestyle Disease or NCD (non communicable diseases / diseases of civilization) are diseases that appear to increase in frequency as countries become industrialized and life span increases.
The concept of pathya apathya w.s.r. to charak samhitabrijeshbhu
Ayurveda has holistic and scientific approach in health management. It emphasizes much more on diet and regimen along with medicines. The diet and regimen which is beneficial to the body and gives the happiness to the mind is known as Pathya and opposite to that is known as Apathya. Most of the health problems develop due to the faulty eating habits and regimen. Ayurveda deals with the pathya vyavastha (planning of diet- dietetics) in a very scientific way. The planning of diet mentioned in our classical literature is very rational and based on certain principles. Lot of importance is given to the diet with regard to its processing, quality, quantity and so on.
Due consideration is given to the atmosphere, psychological condition, status of health, digestion etc. of the person while dealing with this issue. The diet should also be planned according to the age, season, habitat and the preference of the person.
Update on Ayurveda & Unani - 2009 on 14-15th November 2009 in Bal Gandharv Rangmandir, Pune organised by Maharastra University of Health Sciences, Regional Centre, AUNDH, Pune
Kayachikitsa IMP Schlok – Part 1 - PPT
By Prof. Dr. R. R. Deshpande
• This PPT has following features –
• Imp Contents – Definition of Chikitsa, Definition of Sharir, Chatushpad, Chikitsa dhistit Purush, Pathya –Apathya, Yukti Vyapashraya Chikitsa, Santarponattha Vyadhi, Vyadhi Samprapti, Causes of Vata,Pitta & Kapha Prakop, Shat Kriya Kal, Clinical Features of Vata,Pitta & Kapha Prakop, Vyadhi kshamatva,Dosha Pak & Dhatu Pak,Aam etc
• Visit – www.ayurvedicfriend.com
Phone – 922 68 10 630
shotha nidana, poorva roopa, roopa, upashaya, samprapthi, chikitsa according to charaka, sushrutha, ashtanga hridaya, ashtanga sangaraha
you can get detail description on shotha from this presentation.
Ayurveda a Food Science perfectly deals with the different kinds of food preparation which can be utilized in day to day life according to prakritti(basic constitution), desha(place), dosha(humors), kala(time).
Kayachikitsa IMP Schlok – Part 1 - PPT
By Prof. Dr. R. R. Deshpande
• This PPT has following features –
• Imp Contents – Definition of Chikitsa, Definition of Sharir, Chatushpad, Chikitsa dhistit Purush, Pathya –Apathya, Yukti Vyapashraya Chikitsa, Santarponattha Vyadhi, Vyadhi Samprapti, Causes of Vata,Pitta & Kapha Prakop, Shat Kriya Kal, Clinical Features of Vata,Pitta & Kapha Prakop, Vyadhi kshamatva,Dosha Pak & Dhatu Pak,Aam etc
• Visit – www.ayurvedicfriend.com
Phone – 922 68 10 630
shotha nidana, poorva roopa, roopa, upashaya, samprapthi, chikitsa according to charaka, sushrutha, ashtanga hridaya, ashtanga sangaraha
you can get detail description on shotha from this presentation.
Ayurveda a Food Science perfectly deals with the different kinds of food preparation which can be utilized in day to day life according to prakritti(basic constitution), desha(place), dosha(humors), kala(time).
Health: objective, subjective, or other?Mark Sullivan
In this presentation, I examine how we define and perceive health. Is it an objective, observed phenomenon? Is it a subjective, experienced phenomenon? Or some combination of the two, captured by Health-Related Quality of Life (HRQL) measures? Here, I argue that health is not objective or subjective or a combination, but the capacity for meaningful action.
Period there is gradual but progressive loss of ovarian follicular activity. Perimenopause is a period around menopause 40 55 year presenting with Psychological and somatic symptom such as mood disturbance, insomnia, anxiety, memory loss, irritability, weakness, pain, stiffness, tension, headache. In this society everyone is attentive towards a women in her illness or during her pregnancy but no one and she herself is not concern about the disturbances felt during perimenopausal period. In ayurvedic classics under the heading of artavakshaya the age of Rajonivrutti is said to be around 50 yrs. Prevalence of psychological and somatic symptoms is seen in 80 of women at perimenopausal period. Symptoms and disturbance observed in perimenopause period are vata kupita lakshana, For symptomatic management as well as for prevention in moderm medical H, R.T is recommended in spite of its benefits overall compliances with HRT is poor. In addition to high price it has many side effects like weight gain, Breast cancer, tenderness and pain in breast. Dr. Kaveri Patil | Dr. Shobha B Nadagouda "Rajonivritti (Perimenopause) - Ayurvedic Disease Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-5 , August 2022, URL: https://www.ijtsrd.com/papers/ijtsrd51743.pdf Paper URL: https://www.ijtsrd.com/medicine/ayurvedic/51743/rajonivritti-perimenopause--ayurvedic-disease-review/dr-kaveri-patil
An Observational Study on Epidemiology of Tamaka Shwasa W.S.R to Bronchial As...ijtsrd
Tamaka Shwasa is a major disease of Pranavaha srotas which may disturb the daily activities of an affected individual. The chief doshas involved in pathogenesis of this disease are Vata and Kapha. Ayurvedic explanations under Tamaka Shwasa closely resembles with Bronchial asthma. Asthma is defined as a chronic inflammatory disease of airways which is characterized by hyper responsiveness of the tracheobronchial tree to various stimuli. It is manifested physiologically by wide spread narrowing of the air passages, which can be eased spontaneously or as a result of therapy, and clinically by paroxysms of dyspnoea, wheezing and cough. The etiological factors of this disease hints on few epidemiological indicators that has to be revisited in the present scenario. This observational study was conducted in 27 patients to evaluate the epidemiology of Tamaka Shwasa. Datas regarding age, sex, religion, habitat, marital status, socioeconomic status, education, occupation, family history, dietary habit, bowel habit, sleep, addiction, treatment history, chronicity, Deha Prakriti, Manasa Prakriti, Sara, Samhanana, Pramana, Satmya, Satva, Status of Agni, Abhyavaharana Shakti, Jarana Shakti and Vyayama Shakti are thoroughly analysed in this study. Dr. Harsha Radhakrishnan | Dr. Jaya Saklani Kala | Dr. Pranavukumar. C. K "An Observational Study on Epidemiology of Tamaka Shwasa W.S.R to Bronchial Asthma" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-6 , October 2021, URL: https://www.ijtsrd.com/papers/ijtsrd47539.pdf Paper URL : https://www.ijtsrd.com/biological-science/other/47539/an-observational-study-on-epidemiology-of-tamaka-shwasa-wsr-to-bronchial-asthma/dr-harsha-radhakrishnan
Cardio-vascular and psychoneurological pathologies are the main topic of R&D Centre "Veritas" - www.angio-veritas.com and Clinic of vascular innovations - www.inno-health.com (Clinic of healthy vessels) medical activity. We have used a unique technology for individual angiotherapy with evidence-based technologies for vascular screening and angiomarkers with the aim to restore brain and spinal disorders at the various stages of the disease. We have treated the following diseases: https://inno-health.com/en/mylikuemo/
The author of these technologies is Ulyana Lushchyk, Acad. of Ukrainian Academy of Technological Science - www.Lushchyk.org
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
A survey study of symptoms of aids with ayurvedic perspective
1. DR D.Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE ,
PIMPRI –PUNE 12
DEPARTMENT OF
AYURVED
SAMHITA & SIDDHANTA
// SHRI//
2. -TITLE-
“A SURVEY STUDY OF SYMPTOMS OF AIDS WITH AYURVEDIC
PERSPECTIVE
WITH SPECIAL REFERENCE TO CHARAK SAMHITA”
Under Guidance of
Dr.Shital R Rasane
By
Dr.Saurabh B. Kadam
H.O.D.
Dr. Mrudula V. Joshi
4. • A.I.D.S. one of the major health problems encompassing the whole world.
• At this time, there is No Treatment for cure A.I.D.S. in modern medical science.
• In Ayurveda, A.I.D.S. is not described as disease itself.
But it can be studied by doing survey of patients suffering from A.I.D.S.
• It would also help to identify exact Dosha Dushya Samurchana and Samprapti
along with occurrence of symptoms.
5. All other medical sciences identify new diseases every year. But at
similar junctures, Ayurveda views and responds to it on the basis of
the changes in signs, symptoms and corresponding change in
samprapti. Dosha Dushya Sammurchana is used for the treatments
of various diseases at different Vyadhi Avastha in Ayurveda
Today, we cannot exactly identify A.I.D.S. according to Ayurveda. By
some Ayurvedic Vaidya, A.I.D.S. correlates to ‘Rajayakshma
(Shosha)’, some correlates to ‘Ojakshaya’, or some correlates with
both above. There is confusion that, “What is A.I.D.S. according to
Ayurvedic Perspective?’’
6. • Previous study on A.I.D.S. done on the basis of
treatment or drugs,
but there were no any detail previous study of A.I.D.S.
on the basis of
Ayurvedic perspective correlative with Rajayakshama
and Ojakshaya.
This again is going to help the treatment aspect of
A.I.D.S
7. Hypothesis:
• H0: A.I.D.S. does not correlate with either Rajayakshma or
Ojakshaya.
• H1: A.I.D.S. Correlate to Rajayakshma.
• H2: A.I.D.S. Correlate to Ojakshaya.
• H3: A.I.D.S. Correlate to both Rajayakshma and Ojakshaya.
9. Aim:
To Study the Symptoms of H.I.V. positive
patient’s according to Ayurvedic
Perspective with special reference to
Charak Samhita.
10. Objectives:
• Assess the correlation of Rajayakshama symptoms described in
Charak Samhita and symptoms seen in H.I.V. positive patient.
• Assess the correlation of Ojakshaya symptoms described in
Charak Samhita and symptoms seen in H.I.V. positive patient.
• Compilation of all references about H.I.V. and A.I.D.S. from various
books of modern science and internet data.
11. •Study of symptoms of A.I.D.S. as per Ayurvedic
perspective.
•Compilation of all references about Rajayakshma from
Charak Samhita.
•Compilation of all reference about Ojas and Ojakshaya
from Charak Samhita.
•Correlation study of Rajayakshma and Ojakshaya
Symptoms described in Charak Samhita with symptoms
shown in H.I.V. Positive Patients with the help of
questionnaire done for survey study.
13. Literary Study
• Literature of H.I.V. and A.I.D.S. is compiled from Medicines
books of Modern Medical science and new researches from
internet.
• Literature of Rajayakshma and Ojakshaya from Charak
Samhita, its Commentary and Associated Texts.
14. Survey Study
• Questionnaire is prepared to assess the presence symptoms of
Rajayakshma & Ojakshaya in H.I.V. positive patient and to find
out Ayurvedic perspective of A.I.D.S.
• Survey is done using questionnaire which includes following
points :
• Symptoms of Rajayakshma
• Symptoms of Ojakshaya
• Patient for surveys are approached in about 14th H.I.V. Positive
Patient’s Child Care Centres.
• Sample Size – 100 Individuals are considered for this Survey
study.
15. METHODS
•Questionnaires are filled by collecting inputs from the H.I.V.
positive patients which includes a consent form duly signed
by them.
•Data is collected from the Questionnaire provided by the
H.I.V. positive patients from whom Observations are drawn.
•Statistical analysis of collected data is done and results
observed are used for the final Conclusion.
16. CRITERIA OF ASSESSMENT
Inclusion Criteria:
• Already diagnosed Patients of H.I.V. antibody test positive minimum 2
year Ago.
• Age group of 25 - 50 years irrespective of sex, religion, economic &
marital status.
Exclusion Criteria:
• Age below 25 years and above 50 years.
• Patients which are not suffering from A.I.D.S. or not H.I.V. antibody test
positive.
• Patients having H.I.V. antibody test positive but not willing to this survey.
18. LITERARY STUDY
Compilation of data of AIDS from Medicine books of
Modern Medical science.
Compilation of data of Rajayakshma and Ojakshaya from
Charak Samhita, its Commentary and Associated Texts
Interpretation of data
19. OBSERVATION DATA
Preparation of survey questionnaire for H.I.V. Positive Patient with informed
written consent
Selection of Patients for the Survey Study
Comparative Study of Symptoms shown in H.I.V. Positive Patients with
Rajayakshma and Ojakshaya Symptoms according to Questionnaire
20. Collection of Data and Categorization
Assessment
Discussion
Conclusion
Summary
27. aggravated Tridosha produce Ama,
Agnimandya, Dhatwagnimandya
Strotasavarodha and Strotodushti
Dhatukshaya
Alpa Vyadhi Kshamatwa, Daurbalya
Body affects with various Vaydhi
• A.I.D.S.
29. ANUPSHAYA:
•Improper and unhealthy Aahar-Vihar
like vishamashana
•Shrama-kashta i.e. heavy work mentally,
physically
•Not Following Swathawritta
• Vegavarodha etc. Rajayakshma hetus.
31. CORRELATION
According to Ayurveda, the A.I.D.S. disease
may be correlated with
‘Rajayakshma (Kshaya)’ and 'Ojakshaya‘
i.e. clusters of diseases.
32. Some common things we seen in AIDS and
Rajayakshma are,
• Both have clusters of diseases and Symptoms.
• Both are related to Vyadhikshamatwa (immune deficiency)
• Shosha of Rasadhi Sapta dhatu seen in both
• Opportunistic infection seen in both
• Physical and mental activity in both diseases seen low.
• Treatment of both is same as improve immune and Saptadhatu
Vardhaka Chikitsa.
33. Symptoms of Rajayakshma H.I.V./A.I.D.S. Symptoms which can correlate to or
Include in symptoms of Rajayakshama
Kasa Chronic cough with expectorant, pneumonia,
Pulmonary tuberculosis
Recurrence of URTI & LRIT
Amsaabhitapa Burning sense in shoulder and scapula
Svarabheda Verbal Croakiness, Rashes, sores or lesions in the
mouth or nose, Trouble swallowing, Recurrence of
URTI & LRIT
Jirna Jwara Recurring fever, chills , and night sweats
Parshvashoola Joint pain and Muscle aches
Shiroruja Severe headache
34. Symptoms of Rajayakshma H.I.V./A.I.D.S. Symptoms which can correlate to or
Include in symptoms of Rajayakshama
Rudhirachardi in advance stage- vomiting with blood
Kaphavaman Nausea and Vomiting
Chronic cough with expectorant
Shvasa shortness of breath
Varchabheda Persistent diarrhea
Aruchi tastlessness
35. • Early Symptoms of H.I.V. can correlate to
Trirup and shadrup Rajayakshma
And advanced symptoms of HIV/AIDS can correlate to
Ekadashrup Rajayakshma.
• A.I.D.S. is characterized as an end stage
Opportunistic infection with all three doshas vitiated.
• We are observing symptoms of different diseases or different
opportunistic infection in A.I.D.S. patients.
So, A.I.D.S. can be also called as, “King of Diseases”.
36. Some common things we seen in A.I.D.S. and
Ojakshaya are,
• Both have clusters of diseases and Symptoms.
• Both are related to immune deficiency
• Manovahastrotas Dushti seen in both
• Rasa Dhatu Kshaya seen in both
• Opportunistic infection seen in both
• Physical and mental activity in both diseases observed low.
• Treatment of both is same as improve immune and Sapta
Dhatuvardhak Chikitsa.
37. Symptoms of Ojakshaya H.I.V./A.I.D.S. Symptoms which can correlate to or
Include in symptoms of Ojakshaya
Bibheti
Abhikshna-Dhyayati
Durmana
The thing A.I.D.S. or H.I.V. infection is socially not
accepted due to Transmission way of H.I.V. so,
patients having fear to expose themselves in front of
society. The person becomes fretful, fear complex,
repeatedly worries without any reason, feels
discomfort, Loss of confidence, develops bad
complexion, negative thoughts.
In the later stages of A.I.D.S.:
Short-term memory loss
Neurological disorders
Mental confusion
Coma
38. Symptoms of
Ojakshaya
H.I.V./A.I.D.S. Symptoms which can correlate to or Include in
symptoms of Ojakshaya
Daurbalya
Vyathita Indriya
Rooksha
Kshaama
Dushchaya
Recurrence of URTI & LRIT Recurring fever, chills, and night sweats,
Nausea and Vomiting due to etc opportunistic infection patient feels
sever weakness and show following symptoms,
:Joint pain and Muscle aches, Burning sense in shoulder and scapula
: Verbal Croakiness, Rashes, sores, or lesions in the mouth or nose,
Trouble swallowing, Chronic cough with expectorant, Severe headache,
Tinnitus etc.
: Dryness to skin, eye, mouth, stool.
Itching eye-skin etc
: Weight loss, weakness etc.
: loss of complexion
39. •Bhutopaghata:
Bhutopaghata is one of the cause of Ojakshay that
means Assault by evil spirits; micro organisms like
bacteria, virus etc.
•Causes of Ojakshaya are also Predisposes A.I.D.S. in
H.I.V. Infection.
48. •Out of 11 symptoms of Rajayakshma,1 to 4 symptoms
are found only in 1 patient among 100 of sample size i.e.
1%
•30% patients were affected with 5 to 7 symptoms of
Rajayakshma.
•69% patients of H.I.V. are found with 8 to 11 symptoms
of Rajayakshma. Last category of patients i.e. 8 to 11
symptoms are observed Advance stage of H.I.V. (i.e.
A.I.D.S.)
49. OBSERVED SYMPTOMS
N0. OF PATIENT HAVING
SYMPTOMS
N0. OF PATIENT NOT HAVING
SYMPTOMS
Bibheti 96 4
Durbala 99 1
Abhikshana - Dhyayati 87 13
Vyathithendriya 97 3
Dushchchhayo 100 0
Durmana 97 3
Rukshata 97 3
Krushata 98 2
52. Out of 8 symptoms of Ojakshaya,
•Up to 4 symptoms are found in only 1
patient i.e. 1%
•5 to 6 symptoms are covered by 7 % of
whole.
•At the end 92% of whole populations
selected are found 7 to 8 symptoms.
53. Symptoms Category Rajayakshma Ojakshya
Largest symptoms
category 69% 92%
Second Largest
symptoms category 30% 7%
Smallest symptoms
category 1% 1%
55. •This data conclude that, A.I.D.S. is more near with
Ojakshaya rather than Rajayakshma. But we can’t ignore
69% Rajayakshama symptoms relation with A.I.D.S. This
is observed all 11 symptoms of Rajayakshma in patient of
Advance stage H.I.V. infection.
•So, This survey Study goes to hypothesis H3
i.e. A.I.D.S. Correlate to both Rajayakshma and
Ojakshaya.
56. •Due to ART medication, Some Symptoms of
Rajayakshama are Suppressed likes Chardi and
Aruchi. Every patient takes Antiemetic Drug with
ART medication. So this symptom had not observed
clearly yet.
•Due to ART medication, one of Symptom of
Ojakshaya is mentioned in samhita like Rukshata is
increased by ART. Which is side effect of some ART
medicines.
57. •If society and patient’s relatives give mentally and
physically support and confident, then patient can be at
least mentally stable .It also affects patient’s diet.
•After this observational study , we say that, “In This
Disease Patients Affect Mentally More than Physically”.
58. RECOMENDATION
• Ayurveda is best for the treatment covered on the
level of mentally, physically and socially too. This is
opportunity to fulfil definition of healthy person by
W.H.O.
• After this study we can go far treatment part of
A.I.D.S. Which will be Ojakshaya and Rajayaksham
treatment together.